Risk of venous thromboembolism after COVID‐19 vaccination
Damon E. Houghton(Mayo Clinic), Anand Padmanabhan(John Brown University), Ewa Wysokinska(Mayo Clinic in Florida), Meera Sridharan(Mayo Clinic), Leslie Padrnos(Mayo Clinic in Arizona), Robert D. McBane(Mayo Clinic in Arizona), Waldemar E. Wysokiński(Mayo Clinic), Surbhi Shah(Optum (United States)), Lisa Baumann Kreuziger(Medical College of Wisconsin), Aneel A. Ashrani(Mayo Clinic), Ana I. Casanegra(Mayo Clinic), Rajiv K. Pruthi(Mayo Clinic)
Cited by 45
Related Papers
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
|Journal of Thrombosis and Thrombolysis|2016|343
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
|Blood Advances|2023|236
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
|Blood Advances|2018|173
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
|Mayo Clinic Proceedings|2020|122
Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis
|Thrombosis Research|2018|83